`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`~A\. U.S. Food and Drug Administration
`IFI!:::IV'~ Protecting and Promoting Your Health
`FDA Home3 Drug Databases4 Orange Book5
`Oranoe Book: Approved Dru~ Products with Therapeutic Equivalence Evaluations
`Searcll results from the "OB_RX' table for query on "20'1211."
`
`BROMFENAC SODIUM
`Active Ingredient:
`SOLUTION/DROPS;OPHTHALMIC
`Dosage Form;Route:
`BROMFENAC SODIUM
`Proprietary Name:
`COASTAL PHARMS
`Applicant:
`EQ 0.09% ACID
`Strength:
`A201211
`Application Number:
`001
`Product Number:
`May 11, 2011
`Approval Date:
`Yes
`Reference Listed Drug
`RX
`RX/OTC/DISCN:
`ATl
`TE Code:
`Patent and Exclusivity Info for this product: VIew
`
`Return to Electronic Orange Book Home Page6
`FDNCenter for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data - Monthly
`Generic Drug Product Information & Patent Information - Daily
`Orange Book Data Updated Through September 2015
`Patent and Generic Drug Product Data Last Updated November 09, 2015
`
`Links on this page:
`1. http://www .addthis.com/bookmark. php?u508=true&v= 152&username=fdamain
`
`2. http://www.addthis.com/bookmark.php
`
`3. http://www.fda.gov/default.htm
`
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`
`5. ../default.cfm
`
`6. ../default.cfm
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading
`Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website
`Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Contact FDA
`-u-~~-~ a rl iJ ~ ~
`
`http://www _accessdataJdagov/scripts/cder/OO'docs/obdetail_cfin?Appl_ No=201211&T ABLE1 =OB _ Rx
`
`1/2
`
`PAGE 1 OF 2
`
`SENJU EXHIBIT 2242
`INNOPHARMA v SENJU
`IPR2015-00903
`
`
`
`11/10/2015
`
`Orange Book: Approved Drug Products wi h Therapeutic Equivalence Evaluations
`For Government For Press
`Combination Products Advisory Committees Science & Research Regulatory Information Safety
`Emergency Preparedness International Programs News & Events Training and Continuing Education
`Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`2. http://www.addthis.com/bookmark.php
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5. ../default.cfm
`6. ../default.cfm
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=201211&TABLE1=OB_Rx
`
`2/2
`
`PAGE 2 OF 2